AIN457 provided rapid and significant relief of symptoms in up to 81% of patients with psoriasis
- Details
- Category: Novartis

Lilly Reports Third-Quarter 2011 Results
- Details
- Category: Eli Lilly and Company

Abbott Reports Strong Ongoing Third Quarter Results
- Details
- Category: Abbott

Bristol-Myers Squibb Announces Changes in Senior Management Team
- Details
- Category: Bristol-Myers Squibb

Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals
- Details
- Category: Abbott

Roche reports positive study of Herceptin given by subcutaneous injection
- Details
- Category: Roche

Novartis drug Gilenya® (fingolimod) has more than 20,000 patient-years of exposure
- Details
- Category: Novartis

More Pharma News ...
- Bayer HealthCare and Onyx Pharmaceuticals Restructure Global Oncology Partnership
- Roche achieves significant progress with personalised healthcare
- Humana and Pfizer Form Research Partnership
- New Study Shows Cialis® Significantly Improved Study Endpoints
- Bristol-Myers Squibb Foundation Announces Collaboration with World Health Organization's Stop TB Department
- AstraZeneca increases investment in China with new $200 million manufacturing facility
- Findings from Two-Year Pivotal Phase III TEMSO Trial